Published in Vojnosanit Pregl on February 13, 2001
Array-based DNA methylation analysis in classical Hodgkin lymphoma reveals new insights into the mechanisms underlying silencing of B cell-specific genes. Leukemia (2011) 0.92
Triple-way therapeutic approach for paraganglioma-dependent erythrocytosis: drugs and surgery plus "multi-manner" apheresis. Med Oncol (2007) 0.90
The application of hard contact lenses in patients with congenital nystagmus. Fortschr Ophthalmol (1989) 0.87
Anticardiolipin antibodies in women with unexplained infertility. Physiol Res (2004) 0.78
[Current knowledge on cryopreservation of spermatozoa, ovum cells and zygotes]. Med Pregl (1998) 0.77
[Clinical study of the therapeutic value of Kybernin in the treatment of antithrombin III deficiency]. Med Pregl (1991) 0.76
New cellular therapies: is there a role for transfusion services? Vox Sang (2009) 0.76
Collection strategies and cryopreservation of umbilical cord blood. Transfus Med (2007) 0.75
[Double malignancies, coincidence or pathogenetic relationships]. Med Pregl (1982) 0.75
[Pancytopenia within the framework of paroxysmal nocturnal hemoglobinuria (case reports of 7 patients)]. Med Pregl (1984) 0.75
[Spontaneous general fibrinolytic activity of blood in hypertension]. Med Pregl (1977) 0.75
[Treatment of a severe form of aplastic anemia with androgens, immunosuppressive agents, bone marrow allotransplantation and splenectomy]. Vojnosanit Pregl (1982) 0.75
Aclarubicin in the treatment of de-novo acute myelocytic leukaemia. Bone Marrow Transplant (1989) 0.75
The use of therapeutic plasma exchange for treatment of acute polyradiculoneuropathy. Transfus Sci (1995) 0.75
[Exploratory laparotomy for improved assessment of the extent of Hodgkin's disease]. God Vojnomed Akad (1985) 0.75
[The significance of tumor suppressor genes and viral oncoproteins in the onset of malignant cell transformation]. Vojnosanit Pregl (1996) 0.75
[Thrombocyte adhesiveness in patients with the anemic syndrome]. Med Pregl (1976) 0.75
[Our experiences with immunosuppressive therapy of rheumatic diseases]. Med Arh (1974) 0.75
[Secondary myelodysplastic syndrome after autologous transplantation of hematopoietic stem cells in a female patient with Hodgkin's disease]. Vojnosanit Pregl (2001) 0.75
[A severe form of falciparum malaria associated with staphylococcal endocarditis]. Vojnosanit Pregl (2002) 0.75
[Humoral and cellular immunity in chronic lymphatic leukemia]. Med Pregl (1980) 0.75
[The nervous system, stress and immunity]. Vojnosanit Pregl (1986) 0.75
[Biochemical changes in thrombocyte concentrates stored for 5 days]. Vojnosanit Pregl (2001) 0.75
Therapeutic leukapheresis. Transfus Sci (1991) 0.75
[Transplantation of bone marrow cells]. Vojnosanit Pregl (1988) 0.75
[Ten new lessons in hemostasis]. Vojnosanit Pregl (1999) 0.75
[Retinoids and vitamin A in the treatment of malignant diseases with a report of a patient with acute promyelocytic leukemia]. Med Pregl (1987) 0.75
Protocol of the diagnostic, therapy and follow-up of differentiated thyroid cancer. Med Pregl (1993) 0.75
[Helix pomatia--a source of the anti-A reagent]. Vojnosanit Pregl (1985) 0.75
Secondary structure inducing potential of beta-amino acids: torsion angle clustering facilitates comparison and analysis of the conformation during MD trajectories. Biopolymers (2007) 0.75
[Hematopoietic stem cells--biology and therapeutic use]. Vojnosanit Pregl (1999) 0.75
Evaluation of cryopreserved murine and human hematopoietic stem and progenitor cells designated for transplantation. Vojnosanit Pregl (2000) 0.75
[Platelet activity and the fibrinolytic system of blood in cerebral ischemia]. Med Pregl (1982) 0.75
[The role and morphology of thrombocyte concentrates prepared from a buffy coat]. Vojnosanit Pregl (1995) 0.75
[Identification of bodies of soldiers carbonized in an armored transport vehicle]. Vojnosanit Pregl (1993) 0.75
[Hodgkin's disease terminating in pulmonary carcinoma]. Acta Med Iugosl (1981) 0.75
[Fibrinolysis in ulcer disease]. Med Pregl (1975) 0.75
[Therapeutic use of immunoglobulins]. Vojnosanit Pregl (1999) 0.75
[131-I-lipiodol in therapy of liver carcinoma--methods and case report]. Med Pregl (2002) 0.75
[Antilymphocyte globulin in the treatment of aplastic anemia]. Med Pregl (1993) 0.75
[Therapeutic use of blood products and their recombinant analogs in patients with disorders of hemostasis]. Vojnosanit Pregl (2001) 0.75
[Treatment of Hodgkin's disease with high-dose chemotherapy and autologous stem cell transplantation]. Vojnosanit Pregl (2001) 0.75
[The relation of humoral and cellular immunity and the clinical stage in patients with chronic lymphatic leukemia]. Med Pregl (1983) 0.75
[Acne fulminans associated with prolonged polyarthralgia]. Vojnosanit Pregl (1990) 0.75
[Blood transfusion therapy at the Military Medicine Academy--present possibilities]. Vojnosanit Pregl (2001) 0.75
[Erythrocyte concentrates and their substitutes in the treatment of patients with hypovolemia]. Vojnosanit Pregl (2001) 0.75
[Myocardial infarct after treatment of Hodgkin's disease with vincristine]. Srp Arh Celok Lek (1980) 0.75
[In vivo study of spontaneous and therapy-induced apoptosis in patients with chronic lymphocytic leukemia treated with chlorambucil]. Vojnosanit Pregl (1999) 0.75
[Hemotherapy of hemorrhagic syndromes]. Vojnosanit Pregl (1985) 0.75
[Hemostatic changes during hemodialysis of patients with chronic kidney insufficiency]. Vojnosanit Pregl (1983) 0.75
Nonsteroidal anti-inflammatory drugs: as inappropriate pharmacotherapy in the elderly? Adv Gerontol (2011) 0.75
Immunophenotypic profile and clinical characteristics in patients with advanced stage mantle cell lymphoma. Med Oncol (2007) 0.75
[Use of apheresis procedures in the treatment of patients with hemobiologic disorders]. Vojnosanit Pregl (1999) 0.75
[Treatment of porphyria cutanea tarda using plasma exchange]. Vojnosanit Pregl (1989) 0.75
[Prions and neurodegenerative diseases]. Vojnosanit Pregl (1998) 0.75
[Significance of blood transfusion in the development of cytotoxic antibodies in patients on hemodialysis]. Vojnosanit Pregl (2001) 0.75
[Long-term preservation of blood cells by freezing]. Vojnosanit Pregl (1999) 0.75
[Primary solitary plasmacytoma of the skin]. Vojnosanit Pregl (1981) 0.75
[Use and efficacy of radioiodine therapy in the treatment of hyperthyroidism]. Med Pregl (1995) 0.75
[Modern principles in the treatment of autoimmune thrombocytopenia]. Vojnosanit Pregl (2004) 0.75
[Viral hepatitis G--current knowledge]. Vojnosanit Pregl (1999) 0.75
[Hemostasis and atherosclerosis]. Vojnosanit Pregl (2000) 0.75
[Validity of the Radonja reagent test for the determination of cholesterol]. Vojnosanit Pregl (1981) 0.75
[Immunomodulating effects of allogenous blood transfusion]. Vojnosanit Pregl (1998) 0.75
Application of therapeutic plasma exchange in hematology. Transfus Sci (1994) 0.75
[Importance and diagnosis of Epstein-Barr virus infection]. Vojnosanit Pregl (1992) 0.75
[Interleukin-8 serum levels in patients with various types of open heart surgical procedures performed under extracorporeal circulation]. Acta Chir Iugosl (2003) 0.75
[Biochemical conversion of blood groups]. Vojnosanit Pregl (1988) 0.75
[Cytokines--physico-chemical properties and major biological characteristics]. Vojnosanit Pregl (2001) 0.75
Mass spectral fragmentation patterns of some new 3,7-dichloro-benzo[1,2-b:4,5-b']dithiophene-2,6-dicarboxylic acid dianilides and 3,5-dichloro-dithieno[3,2-b:2',3'-d]thiophene-2,6-dicarboxylic acid dianilides. II. Rapid Commun Mass Spectrom (1995) 0.75
[Erythrocyte cell aplasia in chronic myeloid leukemia--coincidence or pathogenic link]. Med Pregl (1990) 0.75
[Neurologic disorders in a patient with autoimmune hemolytic anemia]. Vojnosanit Pregl (1999) 0.75
[The first hospital in Svilajnac and the first decree on the activity of the hospital]. Srp Arh Celok Lek (1985) 0.75
[Changes in humoral and cellular immunity in chronic lymphoproliferative diseases]. Med Pregl (1980) 0.75
[Blood coagulation disorders in malignant hematologic diseases]. Med Pregl (1980) 0.75
[Use of fibrin glue prepared from recycled cryoprecipitate in experimental liver surgery]. Vojnosanit Pregl (1999) 0.75
[Perfusion tomoscintigraphy of the myocardium performed with a 7-pinhole collimator]. Med Pregl (1983) 0.75
[Disorders of humoral immunity in patients with Hodgkin's disease]. Med Pregl (1983) 0.75
[Spontaneous general fibrinolytic activity of blood in acute myocardial infarct and ischemic heart disease]. Med Pregl (1977) 0.75
Comparative chemical, biological and clinical studies of 99mtc-glucoheptonate and 99mtc-dimercaptosuccinate as used in renal scintigraphy. Nuklearmedizin (1979) 0.75
[Correlation of cytologic and pathohistologic findings in ultrasonically-guided thin-needle biopsy of abdominal and retroperitoneal organs]. Vojnosanit Pregl (1997) 0.75
Donor leukocyte infusion--the effect of mutual reactivity of donor's and recipient's peripheral blood mononuclear cells on hematopoietic progenitor cells growth. Vojnosanit Pregl (2001) 0.75
[Differentiation of atypical transient myocardial ischemia using radionuclide methods]. Med Pregl (1987) 0.75
[Sodium determination in biological fluids]. Nephrol Ther (2007) 0.75